Investment Strategies

Boosting Thailand’s investment of public funds in biotech will take educating political leaders, and rice farmers, too.

Written byThana Poopat
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Chief scientists, policy makers, and key stakeholders in science and technology development agree that biotechnology has the potential to transform every aspect of Thailand’s economic and social life for the better. But the promise of biotechnology cannot be realized, they argue, unless it is guided by a clear vision, a strong sense of purpose, and broad public appeal.

Most critical is the paltry level of government investment. Thailand’s public expenditures on research and development rank fifty-first among 53 countries surveyed by the World Competitive Yearbook in 2008. Total Thai expenditures on R&D are 0.24 percent of GDP, about a third of Malaysia’s levels and a tenth of Singapore’s.

“Thailand has been investing in biotechnology research as if we were a small-time player,” says Pongthep Akratanakul of the Center for Agricultural Biotechnology. “We’re one of the world’s agricultural powerhouses. There must be something seriously wrong about our self-perception or self-esteem.”

“It’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies